Stuart O Schecter, MD
- SENIOR FACULTY | Medicine, Cardiology
- Hospital Affiliation
- The Mount Sinai Hospital
- Mount Sinai Doctors Manhasset Medical Associates 516-407-4000 516-407-4000
Book an Appointment - Stuart O Schecter, MD
Stuart O. Schecter, MD is the Director of The Mount Sinai Health Network’s Integrated Remote Monitoring System. He oversees the monitoring of implanted cardiac rhythm devices for the network of hospitals, satellite practices, affiliations, and Mount Sinai owned practices and promotes a multi-disciplinary approach to patient care. Dr. Schecter completed his post-graduate training in Internal Medicine and Cardiology at Mount Sinai Hospital and completed his medical degree at the University of South Florida.
Dr. Schecter has implanted over 8000 cardiac devices and has been issued 18 United States patents, many of which are related to Cardiac Rhythm Management devices. He is Faculty of the American College of Cardiology, Faculty of the American Society of Echocardiography and is a Certified Cardiac Device Specialist of the International Board of Heart Rhythm Examiners having presented at international meetings and acting as co-investigator in several landmark cardiac arrhythmia trials. He has combined his expertise in pacemakers and defibrillators with echocardiography and gained a reputation for improving patients’ congestive heart failure symptoms by optimizing cardiac device settings using cardiac ultrasound.
- Aortic Disease
- Atrial Fibrillation
- Cardiac Tumor
- Chest Pain
- Congestive Heart Failure
- Coronary Artery Disease
- Daytime Sleepiness
- ECG / EKG
- Heart Disease in Pregnancy
- Heart Transplant
- Holter Monitor
- Peripheral Vascular Disease
- Sleep Studies
MD, University of South Florida
Residency, Internal Medicine
Mount Sinai Hospital
Mount Sinai Hospital
Schecter SO MD, Greenberg SM MD, FHRS, Hoch D MD, PhD, Jayam V MD , Shin W MD, Roache M PA, Levine J MD. Does the Riata Lead Deliver Adequate Defibrillation Shocks? A Single Center Experience in 289 patients..;.
Schecter SO MD, Fan D MD, Mihalatos M MD, Gopal A MD, Levine J MD, Hoch D MD, Jayam V MD, Greenberg S MD. Regional Myocardial Strain During Hemodynamically Stable Ventricular Tachycardia [abstract]. Heart Rhythm. 2006; 3:. S342.
Schecter SO MD. Utility of Real Time 3D Echocardiography for Predicting Adverse Events in the MADIT II Post-Myocardial Infarction Patient Population [abstract].
Schecter SO MD. The Effects of Atrial Flutter on Left Ventricular Rotation: A Tissue Doppler Study [abstract]. Heart Rhythm. 2005; 2:. S134.
Schecter SO. Obtaining Surface ECGs from Device Electrograms.;.
Schecter SO, Greenberg SM, Hoch DH, Cesa M, Levine JH. Inappropriate discharges of an implantable cardioverter defibrillator secondary to automatic adjustable gain of atrial tachycardia. Pacing and clinical electrophysiology : PACE 1997 Jun; 20(6).
Schecter SO. Pacemaker and Implantable Cardioverter Defibrillator Interaction: Effects of Implantable Cardioverter Defibrillator Discharges on Pacemaker Function. Pacing and clinical electrophysiology : PACE 1997;.
Schecter SO. Clinical Comparison of the Evoked Response Signal to the R-wave Signal in a Single Chamber Pacemaker with Automatic Capture Confirmation. Pacing and clinical electrophysiology : PACE 1997;.
Schecter SO, Teichholz LE, Klig V, Goldman ME. Ultrasonic Tissue Characterization: Review of a Noninvasive Technique for Assessing Myocardial Viability. Echocardiography (Mount Kisco, N.Y.) 1996 Jul; 13(4).
Schecter SO. Guiding Catheters with Side Holes Relieve Pressure Damping and Improve Coronary Blood Flow: Assessment with the Doppler Flowire. Circulation 1994;.
Haber H, Sackner-Bernstein J, Leavy J, Eisenberg S, Koshkarian G, Schecter S, Goldsmith R, Medina N, Yushak M, Lotvin A, Kukin ML, Packer M. Is the Erythrocyte Sedimentation Rate a useful marker of the response to therapy in heart failure?. JACC 1991; 17(2).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Schecter during 2018 and/or 2019. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.